{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T02:06:24Z","timestamp":1773194784606,"version":"3.50.1"},"reference-count":5,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2026.1812743","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T05:28:44Z","timestamp":1773120524000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Recent advances in thromboembolism and oral contraceptives"],"prefix":"10.3389","volume":"17","author":[{"given":"L.","family":"Morimont","sequence":"first","affiliation":[{"name":"Research Unit in Clinical Pharmacology and Toxicology (URPC), NAmur Research Institute for LIfe Sciences (NARILIS), Faculty of Medicine, University of Namur","place":["Namur, Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Foidart","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Liege","place":["Liege, Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.769187","article-title":"Combined oral con-traceptives and venous thromboembolism: review and perspective to mitigate the risk","volume":"12","author":"Morimont","year":"2021","journal-title":"Front Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"110310","DOI":"10.1016\/j.contraception.2023.110310","article-title":"Comparison of estrogenic components used for hormonal contraception","volume":"130","author":"Stanczyk","year":"2024","journal-title":"Contraception"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2024.110727","article-title":"Lower reporting of venous thromboembolism events with natural estrogen-based combined oral contraceptives compared to ethinylestradiol-containing pills: a disproportionality analysis of the Eudravigilance database","volume":"142","author":"Didembourg","year":"2025","journal-title":"Contraception"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.70393","article-title":"Body-identical estrogens in combined hormonal contraceptives: A safer path forward","author":"Chabbert-Buffet","year":"2025","journal-title":"Int J Gynecol Obstet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.36380\/egoj.2020.162166","article-title":"Biological effects of progestins: focus on deep venous thrombosis risk","volume":"2","author":"Skouby","year":"2020","journal-title":"EGO Eur Gynecology Obstetrics"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1812743\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T05:28:45Z","timestamp":1773120525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1812743\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":5,"alternative-id":["10.3389\/fendo.2026.1812743"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1812743","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"article-number":"1812743"}}